You are hereBiblio / Clinical Study Reflections: Another View
Clinical Study Reflections: Another View
| Title | Clinical Study Reflections: Another View |
| Publication Type | Journal Article |
| Year of Publication | 2010 |
| Authors | Spitzig, Patricia |
| Journal | Science & Engineering Ethics |
| Volume | 16 |
| Issue | 4 |
| Pagination | 705-711 |
| Type of Article | Article |
| Publication Language | eng |
| ISSN Number | 13533452 |
| Accession Number | 55613083 |
| Keywords | Federal , Human Research Subjects , Innovation , Institutional , MEDICINE , PUBLIC , Study , WHISTLE , Whistle-blower |
| Abstract | This article provides commentary to the article "Raising Suspicions with the Food and Drug Administration: Detecting Misconduct," and discusses some innovations that would help improve the minimum federal regulations for conducting clinical studies. |
| Notes | Spitzig, Patricia 1; Email Address: pas@public-sector.org; Affiliation: 1: The Public Sector Consortium, Cambridge, MA, USA; Source Info: Dec2010, Vol. 16 Issue 4, p705; Subject Term: INSTITUTIONAL review boards (Medicine); Subject Term: FEDERAL legislation; Subject Term: WHISTLE blowing; Subject Term: PUBLIC interest; Subject Term: MEDICINE -- Research; Author-Supplied Keyword: Federal regulations; Author-Supplied Keyword: Innovation in clinical research; Author-Supplied Keyword: Institutional Review Boards; Author-Supplied Keyword: Study subject input; Author-Supplied Keyword: Whistle-blower; NAICS/Industry Codes: 541712 Reseach and Development in the Physical, Engineering, and Life Sciences (except Biotechnology); Number of Pages: 7p; Document Type: Article |
| DOI | 10.1007/s11948-010-9235-1 |
| Short Title | Clinical Study Reflections: Another View |
